LXRs serve as key metabolic regulators in obesity by modulating lipogenesis, maintaining cholesterol homeostasis, enhancing insulin sensitivity, and inhibiting inflammation. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.